You are here: Industry Insights > Glenmark

News List

Glenmark Pharma receives US FDA nod for seizure treatment drug expresspharma
February 04, 2021
Glenmark Pharmaceuticals said Qudexy extended-release capsules market achieved annual sales of approximately US $120 mn.
Glenmark Pharma gets USFDA approval for Amphetamine Sulfate Tablets expresspharma
January 28, 2021
The tablets are used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, a sleeping disorder.
Glenmark gets final nod for Tadalafil Tablets and tentative approvals for Gabapentin Enacarbil ER Tablets and Apremilast Tablets from US FDA expresspharma
January 04, 2021
Glenmark’s current portfolio consists of 167 products authorised for distribution in the US marketplace.
Glenmark launches Remogliflozin + Vildagliptin FDC in India to treat Type 2 diabetes expresspharma
December 30, 2020
The FDC will be marketed under two brand names Remo V and Remozen V priced at Rs 14 per tab and Rs 28 per day cost of therapy.
Glenmark Pharma and Menarini enter into exclusive licensing agreement for commercialising Ryaltris for European markets expresspharma
December 23, 2020
Glenmark will receive an upfront payment as well as launch and sales based milestone payments from Menarini for Ryaltris sales.
Glenmark Pharma gets ANDA tentative approval for Dabigatran Etexilate Capsules expresspharma
December 22, 2020
It is the generic version of Pradaxa Capsules, 75 mg, 110 mg, and 150 mg, of Boehringer Ingelheim.
Dr. Reddy’s to acquire select anti-allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan pharmaceutical-business-review
December 02, 2020
Dr. Reddy’s Laboratories has entered into a definitive agreement with Glenmark Pharmaceuticals to acquire, subject to completion of certain precedent actions and closing activities, brands Momat Rino (for Russia, Kazakhstan and Uzbekistan) ...
Glenmark gets tentative approval from US FDA for Axitinib Tablets, 1 mg and 5 mg expresspharma
December 02, 2020
Glenmark Pharmaceuticals has received tentative approval by the United States Food & Drug Administration (US FDA) for Axitinib Tablets, 1 mg and 5 mg, the generic version of Inlyta Tablets, 1 mg and 5 mg, of PF Prism C.V.
Dr Reddy’s to acquire select anti-allergy brands from Glenmark in Russia and other CIS countries expresspharma
November 30, 2020
The acquired brands represent two types of products, mometasone mono product and combination of mometasone with azelastine.
Glenmark Pharma secures its position in Dow Jones Sustainability Emerging Markets Index expresspharma
November 27, 2020
Over 800 companies across sectors from the emerging markets were assessed, out of which 100 made it to the prestigious index this year including 11 from India.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page